Best AI Tools for Optometrists 2026: LumineticsCore vs EyeArt
Optometrists today face a growing patient load and a rising prevalence of chronic eye conditions like diabetic retinopathy and age-related macular degeneration. Choosing the right AI diagnostic tool can mean the difference between catching pathology early or missing it entirely. This guide compares the two leading FDA-cleared AI platforms — LumineticsCore and EyeArt — across accuracy, workflow integration, and cost. By the end, you will know exactly which tool aligns with your practice size and screening goals. Both tools operate within the broader category of AI healthcare tools designed to augment clinical decision-making.
How We Selected the Best Tools in 2026
The tools in this guide were selected based on market relevance, real-world deployment evidence, pricing transparency, and measurable value for the target audience. Each tool covers a meaningfully different use case — no padding or duplicates. Tools with misleading pricing, no verifiable user base, or very limited functionality were excluded.
What This Guide Covers — Jump to Any Section
Tool summaries, head-to-head comparison, who each tool is best for, FAQs, and our verdict.
Tools Compared at a Glance
| Tool | Best For | Free Plan | Price | Rating | Our Pick |
|---|---|---|---|---|---|
| LumineticsCore | High-volume diabetic retinopathy screening | No | Subscription-based, custom quote | 4.5/5 | Best for Large Clinics |
| EyeArt | Point-of-care diabetic retinopathy detection | No | Per-screen pricing, custom quote | 4.3/5 | Best for Independent Practices |
Read each tool's full summary below for detailed analysis, real limitations, and our honest verdict.
The 2 Best Tools in 2026 — Reviewed
Each tool below is assessed on its real-world strengths, limitations, and ideal profile. Rankings move from most broadly recommended to most specialised.
#1 — LumineticsCore
LumineticsCore (formerly IDx-DR) is an FDA-cleared autonomous AI system for detecting diabetic retinopathy. It integrates directly with compatible retinal cameras and delivers a binary result — refer or no refer — without requiring a human reader. This makes it a strong choice for large clinics aiming to scale screening throughput.
Where it wins: Fully autonomous operation eliminates the need for a specialist to interpret images.
Where it struggles: Requires specific camera compatibility, limiting flexibility for practices with older equipment.
- Large ophthalmology clinics
- Hospital-based screening programs
- Tele-retina networks
Pricing: Subscription-based, custom quote — Check latest pricing at LumineticsCore →
Our verdict: Best for high-volume practices that want a fully autonomous, FDA-cleared screening solution.
#2 — EyeArt
EyeArt by Eyenuk is an FDA-cleared AI system designed for real-time diabetic retinopathy screening. It works with a wider range of fundus cameras than most competitors and provides a detailed disease severity grade alongside the referral recommendation. Its per-screen pricing model suits smaller practices with variable patient volumes.
Where it wins: Compatible with over 20 fundus camera models, offering broad hardware flexibility.
Where it struggles: Requires a human to operate the camera, so it is not fully autonomous from image capture to result.
- Independent optometry practices
- Primary care clinics with retinal cameras
- Mobile screening units
Pricing: Per-screen pricing, custom quote — Check latest pricing at EyeArt →
Our verdict: Best for independent optometrists who need camera flexibility and a per-screen pricing model.
Head-to-Head: Feature Comparison
| Feature | LumineticsCore | EyeArt |
|---|---|---|
| FDA Clearance | ✓ | ✓ |
| Autonomous Operation | ✓ | ✗ |
| Camera Compatibility | Limited | Broad (20+ models) |
| Severity Grading | ✗ | ✓ |
| Per-Screen Pricing | ✗ | ✓ |
| Subscription Model | ✓ | ✗ |
| Reimbursement Support | ✓ | ✓ |
| Cloud-Based | ✓ | ✓ |
Which Tool Is Right for You?
What the Market Says in 2026
These insights are synthesised from community discussions, forum threads, product reviews, and market conversations — not fabricated. They capture recurring themes from real teams making real decisions in this category.
Large clinics with dedicated retinal cameras consistently report workflow efficiency gains. The autonomous nature of the system is its primary value driver.
Hardware flexibility is a recurring theme among independent practitioners. The ability to use existing equipment significantly lowers the barrier to adoption.
Practices managing high-risk diabetic populations often prefer graded output to triage follow-up appointments more precisely.
Pricing — What You Really Pay
Both LumineticsCore and EyeArt operate on custom pricing models rather than public flat rates. LumineticsCore uses a subscription-based model that typically suits high-volume clinics, while EyeArt offers per-screen pricing that aligns with variable patient volumes. Neither tool offers a free plan. Reimbursement through CPT code 92229 (remote imaging for diabetic retinopathy) is available for both, which can offset per-screen costs significantly for eligible patient populations.
| Tool | Free Plan | Starting Price | Mid Tier | Enterprise |
|---|---|---|---|---|
| LumineticsCore | No | Custom subscription | Custom subscription | Custom |
| EyeArt | No | Custom per-screen | Custom per-screen | Custom |
Pricing changes frequently — always verify on each tool's official website before purchasing.
Quick Pros and Cons for Every Tool
A fast-scan overview of what each tool does well and where it falls short, based on real deployment patterns.
#1 LumineticsCore
- Fully autonomous, no human reader needed
- FDA-cleared for diabetic retinopathy screening
- Limited camera compatibility
- Subscription model may be costly for low-volume practices
#2 EyeArt
- Broad camera compatibility (20+ models)
- Provides disease severity grading
- Requires human camera operator
- Per-screen cost adds up at very high volumes
How Easy Is It to Get Started?
| Tool | Time to First Result | Setup Complexity |
|---|---|---|
| LumineticsCore | 1-2 weeks for installation and staff training | Moderate — requires compatible camera and IT setup |
| EyeArt | Under 1 week for software setup and training | Beginner-Friendly — works with existing cameras |
The biggest onboarding mistake in this category is skipping the initial configuration — most tools require connecting data sources or accounts before delivering meaningful results. Rushing this stage delays time-to-value significantly.
Frequently Asked Questions
What is the best AI tool for optometrists overall in 2026?
The best tool depends on practice size and workflow. LumineticsCore leads for large clinics wanting fully autonomous screening. EyeArt is the better choice for independent practices that need camera flexibility and per-screen pricing.
Which tool has the best free plan?
Neither LumineticsCore nor EyeArt offers a free plan. Both operate on custom pricing models — LumineticsCore via subscription and EyeArt via per-screen fees. Reimbursement through CPT 92229 can offset costs.
How do I choose between LumineticsCore and EyeArt?
Choose LumineticsCore if you run a high-volume clinic and want a fully autonomous workflow. Choose EyeArt if you need broad camera compatibility and prefer paying per screen rather than a flat subscription.
Are these tools worth the investment in 2026?
Yes, for practices screening diabetic patients. Both tools are FDA-cleared, eligible for reimbursement, and can reduce the time specialists spend on routine screenings. ROI depends on patient volume and existing camera infrastructure.
Which tool is best for small teams on a budget?
EyeArt is generally more accessible for smaller practices due to its per-screen pricing model and compatibility with existing cameras. You only pay when you screen, avoiding a fixed monthly cost.
What should I look for when choosing a tool in this category?
Prioritize FDA clearance, camera compatibility, and pricing model. Also consider whether you need autonomous operation or severity grading, as these are the key differentiators between the two leading options.
Key Takeaways
- LumineticsCore is best for large clinics wanting fully autonomous diabetic retinopathy screening
- EyeArt is best for independent practices needing broad camera compatibility and per-screen pricing
- Both tools are FDA-cleared and eligible for CPT 92229 reimbursement
- Neither tool offers a free plan — pricing is custom and volume-dependent
- Camera compatibility is the most common deciding factor for independent optometrists
- Severity grading is available only on EyeArt, which aids patient triage and follow-up
Other Tools Worth Knowing About
- LumineticsCore — Fully autonomous AI that requires no specialist interpretation, ideal for tele-retina programs.
- EyeArt — Broad camera compatibility and detailed severity grading for nuanced clinical decisions.
Related Guides You May Find Useful
A broader look at AI tools across the healthcare spectrum.
Compare AI tools for analyzing clinical and operational data.
AI tools that support clinical research and diagnostic development.
Need More Options?
This list covers the tools built specifically for this use case. If you want to see more general options, browse the full AI Healthcare Tools category or explore every AI tool on theaitoolsbox.com.
Bottom Line: Which Tool Should You Choose?
Bottom Line: For large clinics prioritizing throughput and autonomy, LumineticsCore is the clear choice. For independent optometrists who need hardware flexibility and per-screen pricing, EyeArt is the better fit. The most important buying advice is to confirm camera compatibility first — that single factor will likely determine which tool is viable for your practice.
Last Updated: June 2026 | Written by theaitoolsbox.com editorial team
